Associations Between Gut Microbiota Composition and Impulse Control Disorders in Parkinson's Disease

Area of Science:

• Microbiology
• Neuroscience
• Gastroenterology

Background:

• Impulse control disorders (ICDs) are common non-motor symptoms in Parkinson's disease (PD).
• While dopaminergic therapy is a known factor, individual susceptibility suggests other biological mechanisms are involved.
• The gut microbiome is increasingly recognized for its role in neurological conditions.

Purpose of the Study:

• To investigate the association between gut microbiota composition and the presence of ICDs in Parkinson's disease patients.
• To identify specific bacterial taxa and metabolic pathways linked to ICDs in PD.

Main Methods:

• 16S rRNA gene sequencing was performed on fecal samples from 191 Parkinson's disease patients (14 with ICDs, 177 without).
• Analysis included microbial diversity (alpha and beta) and differential abundance of bacterial taxa.
• Functional pathway analysis was conducted to explore metabolic differences.

Main Results:

• No significant differences in alpha or beta diversity were found between patients with and without ICDs.
• Specific bacterial taxa, including *Methanobrevibacter* and *Intestinimonas butyriciproducens*, were enriched in patients with ICDs.
• Functional analysis revealed enrichment in xenobiotic degradation and nicotinate metabolism pathways in the ICD group.

Conclusions:

• Gut microbial composition and function may play a role in the development of ICDs in Parkinson's disease.
• Specific microbial taxa and metabolic pathways represent potential non-dopaminergic targets for intervention.
• These findings open avenues for microbiome-targeted therapies for ICDs in PD.